You are not logged in. | Log in
In Progress
Clinical

Primary breast cancer

Purpose

The purpose of this study was to identify genes that marks and mediates breast cancer metastasis to the lungs.

Hypothesis

--

Experimental Design

A cohort of 82 breast cancer patients treated at the Memorial Sloan-Kettering Cancer Center, New York was used in a univariate Cox proportional hazards model to relate the expression level of each lung metastasis signature gene with clinical outcome.

Experimental Variables

--

Controls

--

Methods

For the primary breast tumour data, tissues from primary breast cancers were obtained from therapeutic procedures performed as part of routine clinical management. Samples were snap-frozen in liquid nitrogen and stored at ?80 °C. Each sample was examined histologically in cryostat sections stained with hematoxylin and eosin. Regions were dissected manually from the frozen block to provide a consistent tumour cell content of greater than 70% in tissues used for analysis.

Additional Information

Minn, Andy J., Gaorav P. Gupta, Peter M. Siegel, Paula D. Bos, Weiping Shu, Dilip D. Giri, Agnes Viale, Adam B. Olshen, William L. Gerald, and Joan Massagué. “Genes That Mediate Breast Cancer Metastasis to Lung.” Nature 436, no. 7050 (July 28, 2005): 518–24. doi:10.1038/nature03799.

Microarray
Affymetrix HG-U133A
99 Samples Loaded: 99
Human (Homo sapiens)
Nagalla 2013 , Breast Cancer Tissue , Memorial Sloan-Kettering Cancer Center, NY, USA
Mixed Breast Cancer Types
Sample Set Spreadsheet
Please log in in order to upload files.
Samples Preview
Sample ID series IMS IBS IDS ICR
GSM50034 NA Her2 IBD WID ICR3
GSM50035 NA Basal IBE WID ICR2
GSM50036 NA LumA IBD FID ICR3
GSM50037 NA LumB IBE PID ICR1
GSM50038 NA LumB IBD WID ICR2
Please log in in order to upload files.
File
GSE2603_appended.meta.data_Clinical_Samples_v1.csv
Sample Set Spreadsheet
Raw Signal
Raw Signal
  •   |  View in GXB »
Clinical Datasource
Links

Samples Viewer / Editor

All fields are editable except the "Sample ID" column. To edit a cell, click within the cell. To edit a "date" cell, click on the calendar icon. To cancel an edit, press the ESC key.

Sample ID Series IMS IBS IDS ICR Array Sample ID Sample Title DMFS 10Y EVENT DMFS 10Y TIME Disease Free Survival Event Distant Met Free Survival Event Distant Met Free Survival Age At Initial Pathologic Diagnosis Lymph Node Status ER Status PR Status Histology Differentiation Grade Tumor Size Cm Pathology T Stage Bone Metastasis Event Disease Free Survival Years Lung Metastasis Event Lymph Node Examined Count RFS 5Y EVENT Bone Metastasis Free Survival Years HER2 IHC Lung Metastasis Free Survival Years Number Of Lymph Nodes Positive Van T Veer Signature
GSM50034
NA
Her2
IBD
WID
ICR3
400003089
B110-T
DistantMetastasisFree
7.25
DiseaseFree
NA
NA
61
NA
ER-
PR-
NA
2.2
T2
BoneMetastasisFree
7.25
LungMetastasisFree
11
0
7.25
3+
7.25
2
Good Prognosis
GSM50035
NA
Basal
IBE
WID
ICR2
400003090
B114-T
DistantMetastasis
1.84
Recurred/Progressed
NA
NA
61
NA
ER-
PR-
NA
3.8
T2
BoneMetastasisFree
1.84
LungMetastasis
19
1
1.84
N
1.84
3
Bad Prognosis
GSM50036
NA
LumA
IBD
FID
ICR3
400003091
B52-T
DistantMetastasisFree
9.15
DiseaseFree
NA
NA
40
NA
ER+
PR+
NA
3
T2
BoneMetastasisFree
9.15
LungMetastasisFree
19
0
9.15
N
9.15
0
Bad Prognosis
GSM50037
NA
LumB
IBE
PID
ICR1
400003092
B54-T
DistantMetastasisFree
6.86
DiseaseFree
NA
NA
40
NA
ER+
PR+
NA
2.8
T2
BoneMetastasisFree
6.86
LungMetastasisFree
26
0
6.86
NA
6.86
0
Good Prognosis
GSM50038
NA
LumB
IBD
WID
ICR2
400003093
B55-T
DistantMetastasisFree
6.47
DiseaseFree
NA
NA
75
NA
ER+
PR-
NA
2.2
T2
BoneMetastasisFree
6.47
LungMetastasisFree
15
0
6.47
1+
6.47
0
Good Prognosis
GSM50039
NA
LumB
IBE
FID
ICR4
400003094
B56-T
DistantMetastasisFree
7.08
DiseaseFree
NA
NA
55
NA
ER+
PR+
NA
2.1
T2
BoneMetastasisFree
7.08
LungMetastasisFree
19
0
7.08
N
7.08
0
Good Prognosis
GSM50040
NA
Basal
IBE
WID
ICR2
400003095
B57-T
DistantMetastasisFree
7.57
DiseaseFree
NA
NA
57
NA
ER-
PR-
NA
2.8
T2
BoneMetastasisFree
7.57
LungMetastasisFree
19
0
7.57
N
7.57
0
Bad Prognosis
GSM50041
NA
NA
NA
NA
NA
400003096
B59-T
NA
NA
NA
NA
NA
73
NA
ER-
NA
NA
3.5
T2
NA
NA
NA
9
NA
NA
NA
NA
0
NA
GSM50042
NA
Basal
IBE
PID
ICR3
400003097
B61-T
DistantMetastasisFree
4.41
DiseaseFree
NA
NA
73
NA
ER-
PR-
NA
3.5
T2
BoneMetastasisFree
4.41
LungMetastasisFree
35
NA
4.41
N
4.41
0
Bad Prognosis
GSM50043
NA
LumB
IBE
PID
ICR1
400003098
B62-T
DistantMetastasisFree
5.23
DiseaseFree
NA
NA
63
NA
ER+
PR-
NA
5
T2
BoneMetastasisFree
5.23
LungMetastasisFree
15
0
5.23
1+
5.23
0
Good Prognosis
GSM50044
NA
LumB
IBD
PID
ICR1
400003099
B63-T
DistantMetastasisFree
5.62
DiseaseFree
NA
NA
64
NA
ER+
PR-
NA
3.2
T2
BoneMetastasisFree
5.62
LungMetastasisFree
27
0
5.62
N
5.62
0
Good Prognosis
GSM50045
NA
ClaudinLow
IBD
PID
ICR1
400003100
B66-T
DistantMetastasisFree
10
DiseaseFree
NA
NA
58
NA
ER-
PR-
NA
2.8
T2
BoneMetastasisFree
10.75
LungMetastasisFree
31
0
10.75
NA
10.75
0
Bad Prognosis
GSM50046
NA
Basal
IBE
FID
ICR4
400003101
B67-T
DistantMetastasisFree
8.04
DiseaseFree
NA
NA
32
NA
ER-
PR-
NA
1.8
T1c
BoneMetastasisFree
8.04
LungMetastasisFree
18
0
8.04
N
8.04
0
Bad Prognosis
GSM50047
NA
LumA
IBD
WID
ICR2
400003102
B68-T
DistantMetastasisFree
5.41
DiseaseFree
NA
NA
86
NA
ER+
PR+
NA
3.2
T2
BoneMetastasisFree
5.41
LungMetastasisFree
18
0
5.41
N
5.41
0
Bad Prognosis
GSM50048
NA
Basal
IBE
PID
ICR1
400003103
B69-T
DistantMetastasisFree
6.07
DiseaseFree
NA
NA
49
NA
ER-
PR-
NA
1.5
T1c
BoneMetastasisFree
6.07
LungMetastasisFree
6
0
6.07
N
6.07
0
Bad Prognosis
GSM50049
NA
LumA
IBD
PID
ICR1
400003104
B71-T
DistantMetastasisFree
5.5
DiseaseFree
NA
NA
46
NA
ER+
PR+
NA
2.1
T2
BoneMetastasisFree
5.5
LungMetastasisFree
18
0
5.5
N
5.5
0
Good Prognosis
GSM50050
NA
NA
NA
NA
NA
400003105
B72-T
NA
NA
NA
NA
NA
63
NA
ER-
PR-
NA
1.1
T1c
NA
NA
NA
18
NA
NA
NA
NA
0
NA
GSM50051
NA
LumA
IBD
WID
ICR2
400003106
B74-T
DistantMetastasisFree
3.77
DiseaseFree
NA
NA
49
NA
ER+
PR+
NA
6
T3/T4
BoneMetastasisFree
3.77
LungMetastasisFree
21
NA
3.77
N
3.77
0
Good Prognosis
GSM50052
NA
Basal
IBE
WID
ICR3
400003107
B75-T
DistantMetastasisFree
4.56
DiseaseFree
NA
NA
47
NA
ER-
PR-
NA
5
T2
BoneMetastasisFree
4.56
LungMetastasisFree
8
NA
4.56
0-1
4.56
0
Bad Prognosis
GSM50053
NA
LumA
IBD
WID
ICR2
400003108
B76-T
DistantMetastasisFree
3.97
DiseaseFree
NA
NA
82
NA
ER+
PR+
NA
2
T1c
BoneMetastasisFree
3.97
LungMetastasisFree
3
NA
3.97
N
3.97
0
Bad Prognosis
GSM50054
NA
ClaudinLow
IBD
WID
ICR3
400003109
B77-T
DistantMetastasisFree
4.05
DiseaseFree
NA
NA
73
NA
ER-
PR-
NA
3
T2
BoneMetastasisFree
4.05
LungMetastasisFree
16
NA
4.05
0-1
4.05
0
Bad Prognosis
GSM50055
NA
NA
NA
NA
NA
400003110
B53-T
NA
NA
NA
NA
NA
33
NA
ER-
PR-
NA
3.5
T2
NA
NA
NA
15
NA
NA
0-1
NA
0
NA
GSM50056
NA
NA
NA
NA
NA
400003111
B58-T
NA
NA
NA
NA
NA
70
NA
ER+
PR-
NA
5
T2
NA
NA
NA
26
NA
NA
NA
NA
0
NA
GSM50057
NA
NA
NA
NA
NA
400003112
B60-T
NA
NA
NA
NA
NA
46
NA
ER-
PR-
NA
4
T2
NA
NA
NA
39
NA
NA
3+
NA
0
NA
GSM50058
NA
NA
NA
NA
NA
400003113
B70-T
NA
NA
NA
NA
NA
51
NA
ER-
PR-
NA
4
T2
NA
NA
NA
16
NA
NA
2+
NA
0
NA
GSM50059
NA
LumB
IBD
PID
ICR3
400003114
B42-T
DistantMetastasisFree
7.63
DiseaseFree
NA
NA
73
NA
ER+
PR+
NA
2.9
T2
BoneMetastasisFree
7.63
LungMetastasisFree
16
0
7.63
N
7.63
0
Good Prognosis
GSM50060
NA
Her2
IBE
PID
ICR1
400003115
B43-T
DistantMetastasis
3.47
Recurred/Progressed
NA
NA
52
NA
ER-
PR-
NA
4.5
T2
BoneMetastasisFree
3.47
LungMetastasis
26
1
4.62
1+
3.47
0
Bad Prognosis
GSM50061
NA
ClaudinLow
IBD
WID
ICR3
400003116
B44-T
DistantMetastasis
3.96
Recurred/Progressed
NA
NA
61
NA
ER-
PR-
NA
6
T3/T4
BoneMetastasis
3.96
LungMetastasis
26
1
3.96
N
3.96
0
Good Prognosis
GSM50062
NA
LumB
IBE
PID
ICR1
400003117
B45-T
DistantMetastasis
3.07
Recurred/Progressed
NA
NA
68
NA
ER+
PR+
NA
3.5
T2
BoneMetastasisFree
3.07
LungMetastasisFree
23
1
6.17
N
6.17
0
Good Prognosis
GSM50063
NA
ClaudinLow
IBD
PID
ICR1
400003118
B46-T
DistantMetastasis
3.11
Recurred/Progressed
NA
NA
49
NA
ER-
PR-
NA
3.2
T2
BoneMetastasisFree
3.11
LungMetastasis
36
1
5.71
N
3.11
0
Bad Prognosis
GSM50064
NA
Normal
IBE
NA
ICR3
400003119
B47-T
DistantMetastasis
0.94
Recurred/Progressed
NA
NA
70
NA
ER-
PR-
NA
6.5
T3/T4
BoneMetastasis
0.94
LungMetastasis
14
1
0.94
N
1.34
0
Bad Prognosis
GSM50065
NA
Her2
IBD
WID
ICR3
400003120
B48-T
DistantMetastasisFree
5.81
DiseaseFree
NA
NA
54
NA
ER+
PR-
NA
3
T2
BoneMetastasisFree
5.81
LungMetastasisFree
11
0
5.81
3+
5.81
0
Bad Prognosis
GSM50066
NA
ClaudinLow
IBD
WID
ICR3
400003121
B49-T
DistantMetastasis
1.24
Recurred/Progressed
NA
NA
80
NA
ER-
PR-
NA
2
T1c
BoneMetastasis
1.24
LungMetastasis
4
1
1.24
N
1.24
0
Bad Prognosis
GSM50067
NA
Basal
IBE
PID
ICR2
400003122
B50-T
DistantMetastasis
0.77
Recurred/Progressed
NA
NA
78
NA
ER-
PR-
NA
3
T2
BoneMetastasisFree
0.77
LungMetastasis
2
1
0.95
N
0.77
0
Bad Prognosis
GSM50068
NA
LumA
IBD
WID
ICR2
400003123
B51-T
DistantMetastasis
3.48
Recurred/Progressed
NA
NA
57
NA
ER+
PR-
NA
1.7
T1c
BoneMetastasisFree
3.48
LungMetastasis
17
1
6.01
N
3.48
0
Bad Prognosis
GSM50069
NA
Basal
IBD
PID
ICR2
400003124
B73-T
DistantMetastasis
3.83
Recurred/Progressed
NA
NA
73
NA
ER-
PR-
NA
3.2
T2
BoneMetastasisFree
3.83
LungMetastasis
17
1
4.01
N
3.83
0
Bad Prognosis
GSM50070
NA
Her2
IBD
FID
ICR4
400003125
B98-T
DistantMetastasis
3.36
Recurred/Progressed
NA
NA
58
NA
ER-
PR-
NA
2
T1c
BoneMetastasis
3.36
LungMetastasisFree
16
1
3.36
N
6.96
3
Bad Prognosis
GSM50071
NA
Her2
IBD
FID
ICR3
400003126
B100-T
DistantMetastasisFree
5.82
DiseaseFree
NA
NA
78
NA
ER-
PR-
NA
2.5
T2
BoneMetastasisFree
5.82
LungMetastasisFree
14
0
5.82
N
5.82
2
Bad Prognosis
GSM50072
NA
Basal
IBE
FID
ICR4
400003127
B101-T
DistantMetastasisFree
10
DiseaseFree
NA
NA
47
NA
ER-
PR-
NA
3.5
T2
BoneMetastasisFree
10.74
LungMetastasisFree
26
0
10.74
3+
10.74
2
Bad Prognosis
GSM50073
NA
Basal
IBE
FID
ICR4
400003128
B102-T
DistantMetastasisFree
7.25
DiseaseFree
NA
NA
50
NA
ER-
PR-
NA
4
T2
BoneMetastasisFree
7.25
LungMetastasisFree
29
0
7.25
N
7.25
2
Bad Prognosis
GSM50074
NA
LumA
IBD
WID
ICR1
400003129
B104-T
DistantMetastasisFree
7.32
DiseaseFree
NA
NA
49
NA
ER+
PR-
NA
2.95
T2
BoneMetastasisFree
7.32
LungMetastasisFree
19
0
7.32
N
7.32
3
Good Prognosis
GSM50075
NA
ClaudinLow
IBD
WID
ICR2
400003130
B105-T
DistantMetastasisFree
7.32
DiseaseFree
NA
NA
49
NA
ER+
PR+
NA
2.95
T2
BoneMetastasisFree
7.32
LungMetastasisFree
19
0
7.32
N
7.32
3
Bad Prognosis
GSM50076
NA
NA
NA
NA
NA
400003131
B106-T
NA
NA
NA
NA
NA
57
NA
ER+
PR+
NA
2.1
T2
NA
NA
NA
16
NA
NA
N
NA
2
NA
GSM50077
NA
NA
NA
NA
NA
400003132
B107-T
NA
NA
NA
NA
NA
57
NA
ER+
PR+
NA
2.1
T2
NA
NA
NA
16
NA
NA
N
NA
2
NA
GSM50078
NA
Basal
IBE
PID
ICR1
400003133
B112-T
DistantMetastasisFree
6.98
DiseaseFree
NA
NA
41
NA
ER-
PR+
NA
4
T2
BoneMetastasisFree
6.98
LungMetastasisFree
20
0
6.98
N
6.98
1
Bad Prognosis
GSM50079
NA
Basal
IBE
WID
ICR3
400003134
B115-T
DistantMetastasisFree
6.52
DiseaseFree
NA
NA
40
NA
ER-
PR-
NA
5
T2
BoneMetastasisFree
6.52
LungMetastasisFree
16
0
6.52
N
6.52
3
Bad Prognosis
GSM50080
NA
LumA
IBD
PID
ICR1
400003135
B78-T
DistantMetastasisFree
7.25
DiseaseFree
NA
NA
41
NA
ER+
PR+
NA
2
T1c
BoneMetastasisFree
7.25
LungMetastasisFree
28
0
7.25
N
7.25
2
Good Prognosis
GSM50081
NA
LumA
IBD
PID
ICR2
400003136
B79-T
DistantMetastasisFree
5.07
DiseaseFree
NA
NA
81
NA
ER+
PR+
NA
2.4
T2
BoneMetastasisFree
5.07
LungMetastasisFree
12
0
5.07
NA
5.07
1
Good Prognosis
GSM50082
NA
Normal
IBE
NA
ICR1
400003137
B80-T
DistantMetastasisFree
7.11
DiseaseFree
NA
NA
49
NA
ER+
PR+
NA
2.2
T2
BoneMetastasisFree
7.11
LungMetastasisFree
37
0
7.11
2+
7.11
3
Good Prognosis
GSM50083
NA
LumA
IBD
PID
ICR2
400003138
B82-T
DistantMetastasisFree
7.28
DiseaseFree
NA
NA
61
NA
ER+
PR+
NA
2.5
T2
BoneMetastasisFree
7.28
LungMetastasisFree
21
0
7.28
N
7.28
1
Good Prognosis
GSM50084
NA
Normal
IBE
NA
ICR2
400003139
B83-T
DistantMetastasisFree
6.4
DiseaseFree
NA
NA
39
NA
ER+
PR+
NA
4
T2
BoneMetastasisFree
6.4
LungMetastasisFree
23
0
6.4
1+
6.4
1
Good Prognosis
GSM50085
NA
LumB
IBE
PID
ICR2
400003140
B84-T
DistantMetastasisFree
6.5
DiseaseFree
NA
NA
37
NA
ER+
PR+
NA
2.3
T2
BoneMetastasisFree
6.5
LungMetastasisFree
22
0
6.5
2+
6.5
3
Good Prognosis
GSM50086
NA
Her2
IBE
WID
ICR4
400003141
B85-T
DistantMetastasisFree
8.31
DiseaseFree
NA
NA
57
NA
ER+
PR-
NA
4.3
T2
BoneMetastasisFree
8.31
LungMetastasisFree
18
0
8.31
N
8.31
1
Good Prognosis
GSM50087
NA
LumB
IBD
FID
ICR3
400003142
B86-T
DistantMetastasisFree
8.31
DiseaseFree
NA
NA
57
NA
ER+
PR-
NA
4.3
T2
BoneMetastasisFree
8.31
LungMetastasisFree
18
0
8.31
N
8.31
1
Good Prognosis
GSM50088
NA
NA
NA
NA
NA
400003143
B87-T
NA
NA
NA
NA
NA
51
NA
ER+
PR-
NA
2.5
T2
NA
NA
NA
17
NA
NA
3+
NA
1
NA
GSM50089
NA
Normal
IBE
NA
ICR2
400003144
B89-T
DistantMetastasisFree
8.74
DiseaseFree
NA
NA
30
NA
ER-
PR-
NA
3
T2
BoneMetastasisFree
8.74
LungMetastasisFree
30
0
8.74
N
8.74
3
Good Prognosis
GSM50090
NA
LumA
IBD
PID
ICR1
400003145
B90-T
DistantMetastasisFree
6.79
DiseaseFree
NA
NA
34
NA
ER+
PR+
NA
4.3
T2
BoneMetastasisFree
6.79
LungMetastasisFree
21
0
6.79
NA
6.79
1
Good Prognosis
GSM50091
NA
LumB
IBE
WID
ICR4
400003146
B91-T
DistantMetastasisFree
7.19
DiseaseFree
NA
NA
84
NA
ER+
PR-
NA
10
T3/T4
BoneMetastasisFree
7.19
LungMetastasisFree
11
0
7.19
N
7.19
2
Good Prognosis
GSM50092
NA
Her2
IBD
WID
ICR4
400003147
B93-T
DistantMetastasisFree
6.45
DiseaseFree
NA
NA
50
NA
ER-
PR-
NA
2.3
T2
BoneMetastasisFree
6.45
LungMetastasisFree
29
0
6.45
N
6.45
1
Bad Prognosis
GSM50093
NA
Basal
IBE
FID
ICR3
400003148
B97-T
DistantMetastasisFree
7.86
DiseaseFree
NA
NA
64
NA
ER-
PR-
NA
2
T1c
BoneMetastasisFree
7.86
LungMetastasisFree
20
0
7.86
N
7.86
2
Bad Prognosis
GSM50094
NA
Basal
IBE
PID
ICR2
400003149
B103-T
DistantMetastasis
3.22
Recurred/Progressed
NA
NA
57
NA
ER-
PR-
NA
1.3
T1c
BoneMetastasis
3.22
LungMetastasis
15
1
3.65
N
3.22
3
Bad Prognosis
GSM50095
NA
LumA
IBD
WID
ICR3
400003150
B108-T
DistantMetastasis
6.54
Recurred/Progressed
NA
NA
54
NA
ER+
PR+
NA
2.6
T2
BoneMetastasisFree
6.54
LungMetastasisFree
29
0
7.46
N
7.46
1
Good Prognosis
GSM50096
NA
ClaudinLow
IBD
PID
ICR2
400003151
B109-T
DistantMetastasis
1.38
Recurred/Progressed
NA
NA
32
NA
ER-
PR-
NA
6
T3/T4
BoneMetastasisFree
1.38
LungMetastasis
32
1
1.67
N
1.38
2
Bad Prognosis
GSM50097
NA
LumB
IBE
PID
ICR1
400003152
B111-T
DistantMetastasis
5.39
Recurred/Progressed
NA
NA
46
NA
ER+
PR+
NA
1.3
T1c
BoneMetastasis
5.39
LungMetastasisFree
22
0
5.39
N
7.11
2
Good Prognosis
GSM50098
NA
LumA
IBD
WID
ICR2
400003153
B113-T
DistantMetastasis
2.57
Recurred/Progressed
NA
NA
49
NA
ER+
PR+
NA
1.5
T1c
BoneMetastasis
2.57
LungMetastasisFree
22
1
2.57
N
7.53
3
Good Prognosis
GSM50099
NA
LumA
IBD
WID
ICR2
400003154
B81-T
DistantMetastasis
1.3
Recurred/Progressed
NA
NA
31
NA
ER+
PR+
NA
2.5
T2
BoneMetastasis
1.3
LungMetastasisFree
10
1
1.3
NA
5.68
5
Good Prognosis
GSM50100
NA
LumA
IBD
PID
ICR1
400003155
B88-T
DistantMetastasis
5.81
Recurred/Progressed
NA
NA
61
NA
ER+
PR+
NA
4.8
T2
BoneMetastasisFree
5.81
LungMetastasisFree
15
0
7.96
N
7.96
1
Good Prognosis
GSM50101
NA
LumA
IBD
PID
ICR2
400003156
B92-T
DistantMetastasis
6.36
Recurred/Progressed
NA
NA
72
NA
ER+
PR+
NA
2.5
T2
BoneMetastasis
6.36
LungMetastasisFree
19
0
6.36
N
7.58
3
Good Prognosis
GSM50102
NA
Basal
IBE
PID
ICR1
400003157
B94-T
DistantMetastasis
0.67
Recurred/Progressed
NA
NA
48
NA
ER-
PR-
NA
4
T2
BoneMetastasisFree
0.67
LungMetastasisFree
18
1
1.03
N
1.03
1
Bad Prognosis
GSM50103
NA
Basal
IBE
PID
ICR2
400003158
B95-T
DistantMetastasis
1.84
Recurred/Progressed
NA
NA
61
NA
ER-
PR-
NA
3.8
T2
BoneMetastasisFree
1.84
LungMetastasis
19
1
1.84
3+
1.84
3
Bad Prognosis
GSM50104
NA
Normal
IBE
NA
ICR2
400003159
B96-T
DistantMetastasis
6.77
Recurred/Progressed
NA
NA
65
NA
ER+
PR+
NA
2.9
T2
BoneMetastasis
6.77
LungMetastasisFree
18
0
6.77
N
8.89
1
Good Prognosis
GSM50105
NA
LumA
IBD
WID
ICR3
400003160
B99-T
DistantMetastasisFree
7.19
DiseaseFree
NA
NA
54
NA
ER+
PR-
NA
4.5
T2
BoneMetastasisFree
7.19
LungMetastasisFree
19
0
7.19
NA
7.19
1
Good Prognosis
GSM50106
NA
ClaudinLow
IBD
WID
ICR3
400003161
B7-T
DistantMetastasis
1.58
Recurred/Progressed
NA
NA
60
NA
ER-
PR-
NA
10
T3/T4
BoneMetastasisFree
1.58
LungMetastasis
26
1
1.65
N
1.58
15
Bad Prognosis
GSM50107
NA
Basal
IBE
PID
ICR2
400003162
B10-T
DistantMetastasisFree
6.21
DiseaseFree
NA
NA
52
NA
ER-
PR-
NA
6.5
T3/T4
BoneMetastasisFree
6.21
LungMetastasisFree
9
0
6.21
N
6.21
8
Bad Prognosis
GSM50108
NA
LumA
IBD
WID
ICR2
400003163
B11-T
DistantMetastasisFree
3.96
DiseaseFree
NA
NA
52
NA
ER+
PR+
NA
1.8
T1c
BoneMetastasisFree
3.96
LungMetastasisFree
33
NA
3.96
N
3.96
12
Good Prognosis
GSM50109
NA
NA
NA
NA
NA
400003164
B12-T
NA
NA
NA
NA
NA
57
NA
ER+
PR+
NA
2
T1c
NA
NA
NA
21
NA
NA
NA
NA
1
NA
GSM50110
NA
Basal
IBE
FID
ICR4
400003165
B13-T
DistantMetastasisFree
5.19
DiseaseFree
NA
NA
44
NA
ER-
PR-
NA
6.1
T3/T4
BoneMetastasisFree
5.19
LungMetastasisFree
15
0
5.19
N
5.19
1
Bad Prognosis
GSM50111
NA
LumA
IBD
PID
ICR1
400003166
B14-T
DistantMetastasisFree
7.3
DiseaseFree
NA
NA
61
NA
ER+
PR+
NA
5
T2
BoneMetastasisFree
7.3
LungMetastasisFree
33
0
7.3
N
7.3
30
Good Prognosis
GSM50112
NA
Basal
IBE
PID
ICR2
400003167
B15-T
DistantMetastasis
1.18
Recurred/Progressed
NA
NA
43
NA
ER+
PR-
NA
4.5
T2
BoneMetastasis
1.18
LungMetastasis
21
1
1.18
N
1.18
1
Bad Prognosis
GSM50113
NA
NA
NA
NA
NA
400003168
B16-T
NA
NA
NA
NA
NA
56
NA
ER+
PR+
NA
2.6
T2
NA
NA
NA
26
NA
NA
1+
NA
5
NA
GSM50114
NA
LumA
IBD
FID
ICR3
400003169
B17-T
DistantMetastasis
1.3
Recurred/Progressed
NA
NA
62
NA
ER+
PR+
NA
3.5
T2
BoneMetastasis
1.3
LungMetastasisFree
21
1
1.3
N
1.3
20
Good Prognosis
GSM50115
NA
LumA
IBD
WID
ICR2
400003170
B18-T
DistantMetastasisFree
4.42
DiseaseFree
NA
NA
40
NA
ER+
PR+
NA
3.5
T2
BoneMetastasisFree
4.42
LungMetastasisFree
26
NA
4.42
N
4.42
17
Good Prognosis
GSM50116
NA
Normal
IBE
NA
ICR2
400003171
B1-T
DistantMetastasisFree
3.58
DiseaseFree
NA
NA
65
NA
ER-
PR-
NA
7.5
T3/T4
BoneMetastasisFree
3.58
LungMetastasisFree
19
NA
3.58
2+
3.58
4
Bad Prognosis
GSM50117
NA
NA
NA
NA
NA
400003172
B23-T
NA
NA
NA
NA
NA
38
NA
ER+
PR+
NA
1.5
T1c
NA
NA
NA
17
NA
NA
3+
NA
17
NA
GSM50118
NA
LumB
IBD
PID
ICR3
400003173
B24-T
DistantMetastasisFree
6.28
DiseaseFree
NA
NA
72
NA
ER+
PR+
NA
3
T2
BoneMetastasisFree
6.28
LungMetastasisFree
23
0
6.28
N
6.28
5
Bad Prognosis
GSM50119
NA
Basal
IBE
WID
ICR3
400003174
B26-T
DistantMetastasisFree
4.18
DiseaseFree
NA
NA
54
NA
ER-
PR-
NA
4
T2
BoneMetastasisFree
4.18
LungMetastasisFree
31
NA
4.18
1+
4.18
7
Bad Prognosis
GSM50120
NA
NA
IBE
NA
ICR3
400003175
B27-T
DistantMetastasisFree
3.68
DiseaseFree
NA
NA
38
NA
ER+
PR+
NA
4.1
T2
BoneMetastasisFree
3.68
LungMetastasisFree
31
NA
3.68
N
3.68
5
Bad Prognosis
GSM50121
NA
LumA
IBD
PID
ICR1
400003176
B28-T
DistantMetastasisFree
4.12
DiseaseFree
NA
NA
54
NA
ER+
PR+
NA
6
T3/T4
BoneMetastasisFree
4.12
LungMetastasisFree
27
NA
4.12
1+
4.12
6
Good Prognosis
GSM50122
NA
LumB
IBD
FID
ICR4
400003177
B29-T
DistantMetastasis
3.24
Recurred/Progressed
NA
NA
43
NA
ER+
PR+
NA
8
T3/T4
BoneMetastasis
3.24
LungMetastasisFree
36
1
3.24
N
4.07
22
Bad Prognosis
GSM50123
NA
Basal
IBE
FID
ICR4
400003178
B2-T
DistantMetastasisFree
3.9
DiseaseFree
NA
NA
59
NA
ER-
PR-
NA
4.5
T2
BoneMetastasisFree
3.9
LungMetastasisFree
21
NA
3.9
N
3.9
10
Bad Prognosis
GSM50124
NA
NA
NA
NA
NA
400003179
B31-T
NA
NA
NA
NA
NA
87
NA
ER+
PR+
NA
2.9
T2
NA
NA
NA
20
NA
NA
N
NA
2
NA
GSM50125
NA
NA
NA
NA
NA
400003180
B32-T
NA
NA
NA
NA
NA
59
NA
ER-
PR-
NA
7
T3/T4
NA
NA
NA
17
NA
NA
1+
NA
1
NA
GSM50126
NA
NA
NA
NA
NA
400003181
B33-T
NA
NA
NA
NA
NA
38
NA
ER+
PR+
NA
3.5
T2
NA
NA
NA
16
NA
NA
3+
NA
2
NA
GSM50127
NA
Her2
IBD
WID
ICR4
400003182
B3-T
DistantMetastasisFree
5.24
DiseaseFree
NA
NA
59
NA
ER+
PR+
NA
6
T3/T4
BoneMetastasisFree
5.24
LungMetastasisFree
29
0
5.24
1+ (only 1 core pos.)
5.24
4
Bad Prognosis
GSM50128
NA
LumA
IBD
PID
ICR2
400003183
B4-T
DistantMetastasisFree
2.3
DiseaseFree
NA
NA
70
NA
ER+
PR+
NA
3
T2
BoneMetastasisFree
2.3
LungMetastasisFree
11
NA
2.3
1+
2.3
6
Good Prognosis
GSM50129
NA
NA
NA
NA
NA
400003184
B5-T
NA
NA
NA
NA
NA
39
NA
ER+
PR-
NA
6
T3/T4
NA
NA
NA
22
NA
NA
NA
NA
6
NA
GSM50130
NA
Basal
IBE
WID
ICR3
400003185
B6-T
DistantMetastasisFree
3.36
DiseaseFree
NA
NA
54
NA
ER-
PR-
NA
3
T2
BoneMetastasisFree
3.36
LungMetastasisFree
23
NA
3.36
3+
3.36
18
Bad Prognosis
GSM50131
NA
LumB
IBD
FID
ICR3
400003186
B8-T
DistantMetastasis
4.59
Recurred/Progressed
NA
NA
42
NA
ER+
PR+
NA
3.9
T2
BoneMetastasis
4.59
LungMetastasisFree
28
1
4.59
N
6.05
24
Bad Prognosis
GSM50132
NA
NA
NA
NA
NA
400003187
B9-T
NA
NA
NA
NA
NA
74
NA
ER+
PR-
NA
3.9
T2
NA
NA
NA
31
NA
NA
N
NA
29
NA

Group Sets View in Gene Expression Browser

Name  
All Samples Default  View
Immune Benefit Status   View
Immunological Constant of Rejection   View
Molecular Subtype   View
Pathology T Stage   View
In order to make new Group Sets or change settings, please log in.

Module Analysis

Group Set  
All Samples
Immune Benefit Status
Immunological Constant of Rejection
Molecular Subtype
Pathology T Stage
Your bug report has been sent!